Octagos Health, a Houston, Texas-based provider of AI-driven cardiac device monitoring solutions, has raised over $43 million in a Series B equity round.
Investors
The round was led by Morgan Stanley Expansion Capital, with continued support from Mucker Capital and other strategic investors.
Morgan Stanley Expansion Capital, the growth-focused private investment platform of Morgan Stanley Investment Management, targets growth equity and credit investments in technology, healthcare, consumer, and other high-growth sectors. With nearly four decades of experience, it has invested in over 200 companies, leveraging Morgan Stanley's global brand and network.
Octagos Health Use of Funds
The company will use the funding to accelerate its mission to transform cardiac care through advanced artificial intelligence and comprehensive patient monitoring services. The funding will help accelerate growth, enhance the platform, and expand the commercial team and operations.
About Octagos Health
Octagos Health is a company provider of cardiac monitoring solutions, dedicated to improving patient outcomes through advanced technology and comprehensive monitoring services. The company's AI-driven platform offers continuous monitoring and data analysis for patients with implantable cardiac devices, enabling healthcare providers to make informed decisions and deliver timely care. Octagos Health's solutions are designed to seamlessly integrate with electronic health records and provide customizable reporting features, making it an essential tool for modern healthcare institutions.
Funding Details
Company: Octagos Health, Inc.
Raised: $43.0M+
Round: Series B
Funding Month: July 2024
Lead Investors: Morgan Stanley Expansion Capital
Additional Investors: Mucker Capital
Company Website: https://www.octagoshealth.com/
Software Category: Cardiac Monitoring Solutions
Source: https://www.prnewswire.com/news-releases/octagos-health-secures-over-43-million-investment-to-advance-ai-driven-cardiac-device-monitoring-302192393.html